EP1305759A4 - Procede permettant de definir et maintenir l'administration appropriee d'un medicament - Google Patents

Procede permettant de definir et maintenir l'administration appropriee d'un medicament

Info

Publication number
EP1305759A4
EP1305759A4 EP01952562A EP01952562A EP1305759A4 EP 1305759 A4 EP1305759 A4 EP 1305759A4 EP 01952562 A EP01952562 A EP 01952562A EP 01952562 A EP01952562 A EP 01952562A EP 1305759 A4 EP1305759 A4 EP 1305759A4
Authority
EP
European Patent Office
Prior art keywords
consumer
medicine
incentives
information
otc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP01952562A
Other languages
German (de)
English (en)
Other versions
EP1305759A1 (fr
Inventor
M Casey Donald
B Hansen Jerry
Markels Rosalinda
Merlini Cornelius
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Johnson and Johnson Consumer Inc
Original Assignee
Merck and Co Inc
McNeil PPC Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc, McNeil PPC Inc filed Critical Merck and Co Inc
Publication of EP1305759A1 publication Critical patent/EP1305759A1/fr
Publication of EP1305759A4 publication Critical patent/EP1305759A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/13—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered from dispensers
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING OR COUNTING
    • G06Q—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
    • G06Q30/00—Commerce
    • G06Q30/02—Marketing; Price estimation or determination; Fundraising
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H70/00—ICT specially adapted for the handling or processing of medical references
    • G16H70/40—ICT specially adapted for the handling or processing of medical references relating to drugs, e.g. their side effects or intended usage

Definitions

  • the present invention relates generally to criteria for over-the-counter (OTC)
  • osteoporosis or cholesterol reduction to prevent heart disease.
  • cholesterol reduction to prevent heart disease.
  • nicotine transdermal system sold by McNeil Consumer
  • Asymptomatic or chronic conditions require a set of
  • the present invention addresses those needs.
  • the trained product specialist is
  • One application of this invention is in the treatment of high cholesterol. Consumers are
  • lovastatin for potential OTC sale has been developed and tested. When tested, most consumers
  • hepatitis hepatitis or other liver disease.
  • cholesterol lowering agents include but are not limited to statins in
  • simvastatin US tradename ZOCOR®, see US Patent No. 4,444,784
  • dihydroxy simvastatin
  • simvastatin particularly the ammonium or calcium salts thereof; pravastatin,
  • fluvastatin particularly the sodium salt thereof (US tradename LESCOL®, see US
  • This invention describes a method that has been shown to reduce consumer errors in
  • Yet another step involves communication of incentives to maintain long term usage, including incentives to
  • the product specialist advises the consumer to discuss the product and the condition with a
  • Another incentive offered to consumers would be full purchase price refund if, after
  • FIG. 1 is a schematic drawing illustrating the methods of this invention
  • FIG. 2 illustrates the packaging instructions on the carton back label of an OTC medicine
  • FIG. 3 illustrates an incentive coupon used to communicate the offer of a "high value"
  • the first step of this invention provides clear cut
  • back of the carton containing the OTC medicine includes the following four step guidance to the
  • Step 1 Criteria for usage. Parameters of the asymptomatic
  • Step 2 Prohibitions on usage. A clear statement of who should
  • Step 3 An interaction guide. Any and all medicines known to
  • Step 4 Professional consultation criteria. The potential user of the
  • OTC medication is advised in this step to consult a doctor if he or
  • Each carton contains visual media, e.g., a videotape, CD or
  • the videotape typically
  • the videotape reinforces the four step selection criteria on the carton back panel by
  • the videotape is supplemented with printed carton inserts, including a brochure that
  • hints e.g., diet, exercise, weight control
  • helpful dosage and administration advice for
  • visual and other stimuli that can be used to remind a user when to take the medication.
  • reducing medication is not likely to make a person feel any better. That person can only judge the efficacy of the medication by comparing cholesterol levels as determined by periodic blood
  • the product carton provide several forms of incentives.
  • the consumer is provided with
  • name are preferably selected to designate a particular drug or condition which promotes
  • domain name preferably have a sound or connotation corresponding to the medicine in question
  • the product specialist determines that the consumer should not use the medication for any reason.
  • the product specialist can reconfirm the availability of such refund at the outset of or during
  • this invention provides important motivation, i.e., refund, for
  • the method allows for a refund of the
  • Another incentive offered the consumer is free enrollment in a program designed to
  • the program might offer a cookbook on how to prepare
  • the newsletter might also contain valuable coupons for a variety of
  • Another example of a high value incentive is a free blood test or other analytical
  • test provides a strong incentive to continue use of the medication if the test confirms positive

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Primary Health Care (AREA)
  • Business, Economics & Management (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Strategic Management (AREA)
  • Finance (AREA)
  • Development Economics (AREA)
  • Accounting & Taxation (AREA)
  • Game Theory and Decision Science (AREA)
  • Theoretical Computer Science (AREA)
  • General Physics & Mathematics (AREA)
  • General Business, Economics & Management (AREA)
  • Physics & Mathematics (AREA)
  • Marketing (AREA)
  • Economics (AREA)
  • Entrepreneurship & Innovation (AREA)
  • Management, Administration, Business Operations System, And Electronic Commerce (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention porte sur un procédé (figure 1) visant à réduire les erreurs des consommateurs dans la sélection d'un médicament destiné à traiter des états asymptomatiques ou chroniques et encourager l'utilisation à long terme d'un médicament approprié. La première étape de ce procédé consiste à guider progressivement le consommateur pour lui faire comprendre les informations portées sur l'étiquette du médicament, ce qui amène le consommateur, par le biais de certains critères, à déterminer si l'utilisation du médicament est appropriée. Une autre étape consiste à inciter le consommateur à lire le feuillet d'instructions inclus dans l'emballage ou regarder un support visuel tel qu'une cassette vidéo lui expliquant les informations portées sur l'étiquette. Une autre étape consiste à encourager le consommateur à utiliser le médicament sur une longue durée, l'inciter à appeler un service téléphonique gratuit afin de parler avec un spécialiste connaissant bien le produit. Pour les consommateurs autorisés à prendre le médicament, le spécialiste donne des conseils sur l'utilisation correcte du produit. Pour des consommateurs non autorisés, le spécialiste conseille au consommateur de discuter du produit et de son état avec un médecin et lui facilite le remboursement intégral du produit.
EP01952562A 2000-07-11 2001-07-10 Procede permettant de definir et maintenir l'administration appropriee d'un medicament Withdrawn EP1305759A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21751800P 2000-07-11 2000-07-11
US217518P 2000-07-11
PCT/US2001/021643 WO2002005187A1 (fr) 2000-07-11 2001-07-10 Procede permettant de definir et maintenir l'administration appropriee d'un medicament

Publications (2)

Publication Number Publication Date
EP1305759A1 EP1305759A1 (fr) 2003-05-02
EP1305759A4 true EP1305759A4 (fr) 2005-11-02

Family

ID=22811408

Family Applications (1)

Application Number Title Priority Date Filing Date
EP01952562A Withdrawn EP1305759A4 (fr) 2000-07-11 2001-07-10 Procede permettant de definir et maintenir l'administration appropriee d'un medicament

Country Status (3)

Country Link
EP (1) EP1305759A4 (fr)
CA (1) CA2415664A1 (fr)
WO (1) WO2002005187A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102011077248B3 (de) 2011-06-09 2012-09-27 Hilti Aktiengesellschaft Verwendung eines Inhibitors, Harzmischung, Reaktionsharzmörtel, Zweikomponenten - Mörtelsystem und dessen Verwendung sowie Patrone, Kartusche oder Folienbeutel enthaltend ein Zweikomponenten - Mörtelsystem
DE102011077254B3 (de) 2011-06-09 2012-09-20 Hilti Aktiengesellschaft Verwendung einer Inhibitorkombination, Harzmischung, Reaktionsharzmörtel, Zweikomponenten - Mörtelsystem und dessen Verwendung sowie Patrone, Kartusche oder Folienbeutel enthaltend ein Zweikomponenten - Mörtelsystem

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2272099A1 (fr) * 1996-11-19 1998-05-28 The Procter & Gamble Company Plaquette aide-memoire pour medicaments et procede permettant d'ameliorer ou de faciliter l'observation par un patient de traitements medicamenteux complexes

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
No Search *

Also Published As

Publication number Publication date
CA2415664A1 (fr) 2002-01-17
WO2002005187A1 (fr) 2002-01-17
EP1305759A1 (fr) 2003-05-02

Similar Documents

Publication Publication Date Title
Myers Adherance to Treatment in Medical conditions
US5799981A (en) Pharmaceutical marketing device and system
Krueger et al. Improving adherence persistence: A review assessment of interventions description of steps toward a national adherence initiative
US7891488B2 (en) Interactive product selection system
US5803499A (en) Product marketing booklet
Insull The problem of compliance to cholesterol altering therapy
Rantucci Pharmacists talking with patients: a guide to patient counseling
Fiore Smoking cessation: Clinical practice guideline
Morelli et al. Sample medication dispensing in a residency practice
CA2512716A1 (fr) Methode de gestion de la deselection d'un medicament
US20040048775A1 (en) Method of qualifying and maintaining appropriate drug administration
Driesen et al. How do pharmacists manage acute diarrhoea in an 8-month-old baby? A simulated client study
EP1305759A1 (fr) Procede permettant de definir et maintenir l'administration appropriee d'un medicament
Christensen " Increasing Safe Medication Practices in Older Adults
Riggs A family caregiver policy agenda for the twenty-first century
Silverman et al. Pills & the Public Purse: The Routes to National Drug Insurance
Mallet Counseling in Special Populations: The Elderly Patient: The aging process creates special problems for pharmacists in delivering pharmaceutical services.
Lanzafame Issues in the acquisition, development, and use of technology in health care
Skutnik et al. The impact of initial noncompliance in Canadian retail pharmacies: a descriptive examination
Fiore Treating tobacco use and dependence; 2008 guideline
Curran et al. Sources of drug information available to consumers
Simeungba et al. Development of Tailor-made Interventions to improve clinical outcomes of patients with diabetes at Setthathirat hospital, Laos PDR
Groom et al. Promoting appropriate drug use in missionary health facilities in Cameroon
Gilhooley Heal the damage: prescription drug consumer advertisements and relative choices
JORDAN Psychiatry Practice Boosters

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20030115

AK Designated contracting states

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

A4 Supplementary search report drawn up and despatched

Effective date: 20050914

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20061018